Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein.
Lu Q, Zhang Z, Li H, Zhong K, Zhao Q, Wang Z, Wu Z, Yang D, Sun S, Yang N, Zheng M, Chen Q, Long C, Guo W, Yang H, Nie C, Tong A.
Lu Q, et al. Among authors: sun s.
J Nanobiotechnology. 2021 Jan 29;19(1):33. doi: 10.1186/s12951-021-00768-w.
J Nanobiotechnology. 2021.
PMID: 33514385
Free PMC article.